EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Latest Intestinal Ultrasound Advancements In Inflammatory Bowel Disease

Cathy Lu

Canadian IBD Today · 2024

DOI: 10.58931/cibdt.2024.2124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian IBD Today, 2024. Verfasst von Cathy Lu. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) treatment has evolved from monitoring clinical symptoms to targeting objective measurements of mucosal healing with endoscopic and radiologic imaging. It is well known that clinical symptoms do not match disease severity. Frequent evaluation with radiologic imaging is now the standard of care. Although Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE-II) recommendations do not list radiographic targets as an endpoint due to the “limited ability of the currently available treatments to achieve transmural healing,” this will likely evolve over time particularly with the rapidly growing uptake of intestinal ultrasound (IUS) in clinical trials. For the time being, imaging is considered as an “adjuvant assessment rather than a formal treatment target.”

Zitieren

APA

Lu, C. (2024). Latest Intestinal Ultrasound Advancements In Inflammatory Bowel Disease. Canadian IBD Today. https://doi.org/10.58931/cibdt.2024.2124

Vancouver

Lu C. Latest Intestinal Ultrasound Advancements In Inflammatory Bowel Disease. Canadian IBD Today. 2024. doi:10.58931/cibdt.2024.2124

BibTeX
@article{Lu2024,
  author = {Lu, Cathy},
  title = {Latest Intestinal Ultrasound Advancements In Inflammatory Bowel Disease},
  journal = {Canadian IBD Today},
  year = {2024},
  doi = {10.58931/cibdt.2024.2124}
}
Kostenlos starten →